Colin Broom

1.6k total citations · 2 hit papers
17 papers, 1.2k citations indexed

About

Colin Broom is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Colin Broom has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Colin Broom's work include Cancer therapeutics and mechanisms (5 papers), Gastroesophageal reflux and treatments (2 papers) and Gastrointestinal motility and disorders (2 papers). Colin Broom is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Gastroesophageal reflux and treatments (2 papers) and Gastrointestinal motility and disorders (2 papers). Colin Broom collaborates with scholars based in United States, Netherlands and United Kingdom. Colin Broom's co-authors include David Fitts, Steven P Gelone, I Hudson, Dale N. Gerding, David M. Davidson, Oliver A. Cornely, Thomas Louie, Stuart Johnson, Scott Chasan-Taber and John H. Malfetano and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

Colin Broom

17 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

1997 532 citations W ten Bokkel Huinink, Martin Gore et al. Journal of Clinical Oncology profile →
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

2014 394 citations Stuart Johnson, Thomas Louie et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colin Broom United States	11	481	427	386	361	338	17	1.2k
David Frame United States	16	116 0.2×	180 0.4×	135 0.3×	94 0.3×	242 0.7×	56	873
John M. Malone United States	23	329 0.7×	367 0.9×	34 0.1×	356 1.0×	256 0.8×	38	1.3k
Takahiro Uotani Japan	21	1.1k 2.2×	80 0.2×	77 0.2×	73 0.2×	77 0.2×	78	1.4k
Ruben Orda Israel	17	448 0.9×	100 0.2×	31 0.1×	85 0.2×	177 0.5×	87	870
Luigina Graziosi Italy	16	457 1.0×	70 0.2×	29 0.1×	103 0.3×	348 1.0×	74	1.0k
Emmanuelle de Raucourt France	17	328 0.7×	82 0.2×	19 0.0×	471 1.3×	22 0.1×	54	1.3k
Yafei Zhang China	14	138 0.3×	42 0.1×	40 0.1×	103 0.3×	162 0.5×	44	706
Antonio Russo Italy	17	269 0.6×	12 0.0×	136 0.4×	228 0.6×	205 0.6×	64	1.0k
Dimitrios Haidopoulos Greece	20	442 0.9×	507 1.2×	19 0.0×	283 0.8×	434 1.3×	126	1.7k
L. Verbist Belgium	12	129 0.3×	41 0.1×	143 0.4×	166 0.5×	73 0.2×	20	597

Countries citing papers authored by Colin Broom

Since Specialization

Citations

This map shows the geographic impact of Colin Broom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Broom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Broom more than expected).

Fields of papers citing papers by Colin Broom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Broom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Broom. The network helps show where Colin Broom may publish in the future.

Co-authorship network of co-authors of Colin Broom

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Broom. A scholar is included among the top collaborators of Colin Broom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Broom. Colin Broom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Benepal, T., et al.. (2019). Cancer, mental health and end life simulation (CAMhELS): A novel effectiveness evaluation. Annals of Oncology. 30. v669–v669. 1 indexed citations

Johnson, Stuart, Thomas Louie, Dale N. Gerding, et al.. (2014). Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials. Clinical Infectious Diseases. 59(3). 345–354. 394 indexed citations breakdown →

Bernstein, Jonathan A., Michael Manning, Henry Li, et al.. (2013). Escalating Doses of C1 Esterase Inhibitor (CINRYZE) for Prophylaxis in Patients With Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 77–84.e1. 39 indexed citations

Schranz, Jennifer, Robyn J. Levy, William R. Lumry, et al.. (2012). Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Subcutaneous (SC) Cinryze® (C1 inhibitor (C1 INH) with Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Hereditary Angioedema (HAE). Journal of Allergy and Clinical Immunology. 129(2). AB369–AB369. 4 indexed citations

Gerding, Dale N., Colin Broom, & Steven P Gelone. (2009). Clostridium difficile Infection. Infectious Diseases in Clinical Practice. 17(3). 161–168. 5 indexed citations

Stevenson, James, Richard M. Scher, Mary A. Simmonds, et al.. (1998). Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas. European Journal of Cancer. 34(9). 1358–1362. 18 indexed citations

Creemers, G.J., C J Gerrits, John R. Eckardt, et al.. (1997). Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.. Journal of Clinical Oncology. 15(3). 1087–1093. 66 indexed citations

Huinink, W ten Bokkel, Martin Gore, J Carmichael, et al.. (1997). Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.. Journal of Clinical Oncology. 15(6). 2183–2193. 532 indexed citations breakdown →

Broom, Colin. (1996). Clinical Studies of Topotecan. Annals of the New York Academy of Sciences. 803(1). 264–271. 13 indexed citations

10.

Schellens, Jan H.M., John R. Eckardt, Daniel D. Von Hoff, et al.. (1995). 926 Pharmacokinetics (PK), clinical pharmacodynamics (PD) and safety of chronic oral topotecan (T), in a phase I study. European Journal of Cancer. 31. S192–S192. 4 indexed citations

11.

Hannan, Anthony J., J Weil, Colin Broom, & R P Walt. (1992). Effects of oral pantoprazole on 24‐hour intragastric acidity and plasma gastrin profiles. Alimentary Pharmacology & Therapeutics. 6(3). 373–380. 18 indexed citations

12.

Broom, Colin, et al.. (1991). Effects of low‐dose cimetidine on nocturnal acid secretion in healthy subjects. Alimentary Pharmacology & Therapeutics. 5(1). 61–67. 1 indexed citations

13.

Torphy, Theodore J., Isidore Faiferman, John G. Gleason, et al.. (1991). The Preclinical and Clinical Pharmacology of SK&F 104353, a Potent and Selective Peptidoleukotriene Receptor Antagonist. Annals of the New York Academy of Sciences. 629(1). 157–167. 10 indexed citations

14.

Acton, Gary D & Colin Broom. (1990). A Comparison of Attenuation Compensated Volume Flow Based Doppler Echocardiography and Impedance Cardiography in Healthy Volunteers. American Journal of Noninvasive Cardiology. 4(5). 290–297. 5 indexed citations

15.

Broom, Colin. (1989). Human pharmacokinetics of halofantrine hydrochloride. Parasitology Today. 5. 15–20. 17 indexed citations

16.

Broom, Colin, et al.. (1989). A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2‐receptor agonist.. British Journal of Clinical Pharmacology. 28(4). 435–441. 15 indexed citations

17.

Drossman, Douglas A., Robert S. Sandler, Colin Broom, & Daphne C. McKee. (1986). Urgency and fecal soiling in people with bowel dysfunction. Digestive Diseases and Sciences. 31(11). 1221–1225. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact